CGTLimited DatastaleThomas Martin, MDPhase 1
Chimeric Antigen Receptor T cells (CAR-T, Chimeric Antigen Receptor T cells, Chimeric Antigen Receptor T cells (CAR-T) Targeting BCMA)
Multiple Myeloma; Recurrent Multiple Myeloma · BCMA
#BCMA#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 211Status Discontinued